InsidersTradesSigma
Follow the ODI Pharma AB (publ) share price and the full management transaction log of the company, a listed equity based in Finland. Shares trade on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, ODI Pharma AB (publ) has logged 1 public disclosures. Market capitalisation: €44m. The latest transaction was filed on 15 January 2026 (Purchase). Among the most active insiders: Johan Edewaard. Every trade is free.
1
Insider Decl.
n/a
Thresholds
€3,502
1 ops.
Buy Volume
n/a
n/a
Sell Volume
31Σ signal
Fundamental score
Ranked 26,577 of 29,062 companies
20.3
score / 100
Value16
Quality24
FCF yld-7.5%
Earn yld-13%
EV/EBITDA·
ROE-28%
Gross mgn27%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 15 January 2026
Declarations1 total
10,000 shares@ €0.35020.0049% mcap100.0% of flowAktieISIN SE0013409760FI:A003V318-1
1 of 1 declaration
关于 ODI Pharma AB (publ)
ODI Pharma AB (publ) 是一家瑞典制药公司，在斯德哥尔摩证券交易所上市。它专注于开发医疗保健领域的创新疗法。